Biotricity Achieves $14M Revenue Run Rate In August 2023
Corporate Impact Report concluded better patient outcomes and substantial cost savings, thus accelerating Company's sales growth
August 30, 2023 / Biotricity Inc. (NASDAQ:BTCY)
Biotricity Shows Continued Growth And Strength In Its Fundamentals On Its Path To Profitability; Sees Record Q1-FY2024 Recurring Revenue Growth
Company to report robust performance improvements in its operating metrics
Record Q1-FY2024 recurring revenue growth
Significantly higher margins on technology fees compared to blended margins
Strong control
12 Health Care Stocks Moving In Tuesday’s Pre-Market Session
Gainers Bullfrog AI Hldgs (NASDAQ:BFRG) stock moved upwards by 45.4% to $5.03 during Tuesday’s pre-market session. The company’s…
Biotricity Reports Strong Start To Fiscal Year 2024; Company Estimates Q1-FY24 Revenue To Grow YoY By Over 40%
Company estimates Q1-FY24 revenue to grow YOY by over 40%
Recurring technology fees, customer second-device sales, continue to trend higher
REDWOOD CITY, CA / ACCESSWIRE / July 6, 2023 / Biotricity
Why 1847 Holdings Shares Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Allarity Therapeutics, Inc. (NASDAQ: ALLR) shares surged 87% to $11.78 after the company said the initial data from Phase 2 trial of Ixempra shows potential for improved clinical benefit in DRP-selected metastatic breast cancer patients.
Biotricity’s Return On Capital Employed Overview
Biotricity (NASDAQ:BTCY) brought in sales totaling $2.74 million during Q4 according to data provided by Benzinga Pro. However,…
Biotricity Announces 1-For-6 Reverse Stock Split
Biotricity Holdings, Inc. ("Biotricity" or the "Company") (NASDAQ:BTCY), a medical diagnostic and consumer healthcare technology company, today it will effect a reverse stock split of its common
Biotricity: Q4 Earnings Insights
Biotricity (NASDAQ:BTCY) reported its Q4 earnings results on Friday, June 30, 2023 at 08:00 AM. Here’s what investors…